focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.825
Bid: 1.80
Ask: 1.85
Change: 0.048 (2.46%)
Spread: 0.05 (2.778%)
Open: 1.95
High: 1.998
Low: 1.998
Prev. Close: 1.95
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

Wed, 03rd Apr 2024 16:54

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.

The FTSE 100 index closed up 2.35 points at 7,937.44. The FTSE 250 ended up 39.75 points, 0.2%, at 19,753.64, and the AIM All-Share closed down 0.32 of a point at 742.08.

The Cboe UK 100 ended down 0.1% at 793.01, the Cboe UK 250 closed up 0.1% at 17,166.93, and the Cboe Small Companies ended up 0.7% at 14,656.34.

In European equities on Wednesday, the CAC 40 in Paris ended up 0.4%, while the DAX 40 in Frankfurt ended up 0.5%.

On Wednesday afternoon, there has been some US data for investors to digest.

The US private sector added more jobs in March than a month earlier, numbers from payroll processor ADP showed on Wednesday.

Private sector employment increased by 184,000 jobs in March, rising from 155,000 in February.

February's job growth was ahead of the FXStreet-cited market consensus of 148,000.

Annual wage growth for job-changers rose by 5.1% in March. For job stayers annual wage growth increased by 10%.

"The market is increasingly assuming that a US rate cut is some months away," said Kathleen Brooks, research director at XTB.

"After another strong data report, this time the March ADP private sector payrolls report, the market is increasingly expecting fewer rate cuts from the Fed this year, with the first rate cut currently on a knife edge between July and September."

Meanwhile, a senior bank official said the current strength of the US economy means the Federal Reserve should cut interest rates just once this year, and not until the final quarter.

Atlanta Fed President Raphael Bostic, who is a voting member of the Fed's rate-setting committee this year, told CNBC he now thinks the Fed should make just one cut this year – below the three that were predicted by Fed officials in March.

There was also data on the US service sector.

The seasonally adjusted S&P Global US Services purchasing managers' index edged down to 51.7 in March, a three-month low, from 52.3 in February. Falling closer to the 50-mark separating growth from contraction, it indicates growth decelerated.

Meanwhile, the S&P Global US composite PMI output index fell to 52.1 in March from 52.5 in February.

Separately, the Institute for Supply Management reported that the services PMI edged down to 51.4 in March from 52.6 in February.

"The renewed fall in the ISM services index in March is consistent with the message from the hard data that economic growth is slowing from the unsustainably strong pace in the second half of last year," analysts at Capital Economics said.

Stocks in New York were higher at the London equities close, with the DJIA up 0.2%, the S&P 500 index up 0.4%, and the Nasdaq Composite up 0.6%.

The pound was quoted at USD1.2630 at the London equities close Wednesday, up compared to USD1.2564 at the close on Tuesday. The euro stood at USD1.0827 at the European equities close Wednesday, higher against USD1.0771 at the same time on Tuesday. Against the yen, the dollar was trading at JPY151.72, up compared to JPY151.60 late Tuesday.

In London's FTSE 100, Prudential lost 2.7% to 720.40 pence, after Barclays cut the insurer's price target to 1,390p per share from 1,640p, while Barclays rates the stock at 'overweight'.

In the FTSE 250, International Distributions Services rose 4.3%.

IDS unit Royal Mail proposed a change to its UK letter delivery offering, as it grapples with weaker volumes, in a move which could see "fewer than 1,000 voluntary redundancies".

The measures could trim the net cost of the UK postal universal service operation by GBP300 million per year.

"This is very dependent on how quickly reform is enacted and the rate of letter decline. These savings would allow Royal Mail to continue to invest in the modernisation and transformation of the business to provide products and services that customers want and reduce its environmental impact," IDS said.

On AIM, Genedrive shares surged 39%.

The molecular diagnostics company announced that the UK's National Institute for Health & Care Excellence has recommended in draft guidance that Genedrive's CYP2C19-ID test should be used as the point-of-care test of choice for ischemic stroke and transient ischaemic attack patients.

Brent oil was quoted at USD89.69 a barrel at the London equities close Wednesday, up from USD88.11 late Tuesday.

Gold was quoted at USD2,286.90 an ounce at the London equities close Wednesday, up against USD2,266.55 at the close on Tuesday.

In Thursday's UK corporate calendar, there are full year results from LungLife AI.

The economic calendar for Thursday has a producer price reading from the eurozone at 1000 BST.

There is also a slew of composite PMI data from the eurozone, Germany, and the UK.

Across the Atlantic, there is the weekly initial jobless claims from the US.

Meanwhile, financial markets will be closed in Hong Kong and Shanghai will be closed for Tomb Sweeping Day.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
9 Feb 2023 10:36

Genedrive hearing loss test recommended by UK health department body

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence has preliminarily recommended its antibiotic hearing loss test, the MT-RNR1 ID kit.

Read more
9 Feb 2023 09:13

LONDON MARKET OPEN: BAT falls on sales miss; Entain hit by MGM remark

(Alliance News) - Stock prices in London opened higher on Thursday, as investors digested a mixed set of UK company earnings.

Read more
3 Feb 2023 10:26

AIM WINNERS & LOSERS: 88 Energy surges; Petro Matad plans fundraise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
29 Dec 2022 21:58

IN BRIEF: Genedrive shareholders vote down pre-emption rights power

Genedrive PLC - Manchester-based molecular diagnostics company - Reports that 21% of its shareholders voted against resolution 3 for the reappointment Tom Lindsay as a director at its annual general meeting on Thursday. 32% of its shareholders voted against resolution 5 for the reappointment of David Budd as a director, and 25% of shareholders voted against resolution 6 for the reappointment of Ian Gilham as a director. Adds that 25% of shareholders voted against resolution 10, to authorise the directors to allot equity securities in the capital.

Read more
22 Dec 2022 15:44

UK shareholder meetings calendar - next 7 days

Friday 23 December 
Plexus Holdings PLCAGM
Wildcat Petroleum PLCAGM
Monday 26 December 
no events scheduled 
Tuesday 27 December 
Zambeef Products PLCAGM
Wednesday 28 December 
Evrima PLCAGM
Greencare Capital PLCGM re proposed name change
Lift Global Ventures PLCGM re proposed expansion within the energy sector
Thursday 29 December 
Amte Power PLCAGM
ADVFN PLCAGM
Genedrive PLCAGM
Hotel Chocolat Group PLCAGM
Lekoil LtdEGM re proposed settlement and name change
Online Blockchain PLCAGM
PetroNeft Resources PLCAGM
SkinBioTherapeutics PLCAGM
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
21 Nov 2022 12:19

Genedrive shares slump as loss widens on lack of Covid-19 revenue

(Alliance News) - Genedrive PLC on Monday reported a substantially widened pretax loss as revenue slumped due to a lack of Covid-19 revenue.

Read more
21 Nov 2022 11:15

AIM WINNERS & LOSERS: Real Good Food secures turnaround funds

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
14 Nov 2022 14:32

UK earnings, trading statements calendar - next 7 days

Tuesday 15 November 
AdEPT Technology Group PLCHalf Year Results
BAE Systems PLCTrading Statement
Gear4Music PLCHalf Year Results
Imperial Brands PLCFull Year Results
Land Securities Group PLCHalf Year Results
Melrose Industries PLCTrading Statement
Ninety One PLC and LtdHalf Year Results
R&Q Insurance Holdings LtdQ1 Results
Speedy Hire PLCHalf Year Results
Vesuvius PLCTrading Statement
Vodafone Group PLCHalf Year Results
Wincanton PLCHalf Year Results
Workspace Group PLCHalf Year Results
Wednesday 16 November 
Aristocrat Leisure LtdFull Year Results
Bridgepoint Group PLCTrading Statement
British Land Co PLCHalf Year Results
Castings PLCHalf Year Results
CMC Markets PLCHalf Year Results
Enteq Technologies PLCHalf Year Results
Experian PLCHalf Year Results
Hill & Smith PLCTrading Statement
Mediclinic International PLCHalf Year Results
Nightcap PLCFull Year Results
Premier Foods PLCHalf Year Results
Renold PLCHalf Year Results
Sage Group PLCFull Year Results
Schroder Global Real Estate SecuritiesHalf Year Results
Schroder Real Estate Investment Trust LtdHalf Year Results
SSE PLCHalf Year Results
Thursday 17 November 
Burberry Group PLCHalf Year Results
Close Brothers Group PLCTrading Statement
Fuller, Smith & Turner PLCHalf Year Results
Grainger PLCFull Year Results
Great Portland Estates PLCHalf Year Results
Halma PLCHalf Year Results
Integrated Diagnostics Holdings PLCQ3 Results
Intermediate Capital Group PLCHalf Year Results
International Distributions Services PLCHalf Year Results
Investec PLC and LtdHalf Year Results
Keller Group PLCTrading Statement
Kier Group PLCTrading Statement
Mitie Group PLCHalf Year Results
Pershing Square Holdings LtdQ3 Results
Redcentric PLCHalf Year Results
Seraphim Space Investment Trust PLCQ1 Results
Spirax-Sarco Engineering PLCTrading Statement
Syncona LtdHalf Year Results
Tyman PLCTrading Statement
Virgin Money UK PLCFull Year Results
Zytronic PLCFull Year Results
Friday 18 November 
Bank of Cyprus Holdings PLCQ3 Results
Liontrust Asset Management PLCHalf Year Results
Monday 21 November 
Big Yellow Group PLCHalf Year Results
Compass Group PLCFull Year Results
Dialight PLCTrading Statement
Diploma PLCFull Year Results
Equipmake Holdings PLCFull Year Results
Genedrive PLCFull Year Results
Molten Ventures PLCHalf Year Results
MTI Wireless Edge LtdQ3 Results
NextEnergy Solar Fund LtdHalf Year Results
Polar Capital Holdings PLCHalf Year Results
Sirius Real Estate LtdHalf Year Results
SysGroup PLCHalf Year Results
Virgin Money UK PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
5 Oct 2022 11:40

Genedrive shares surge as pre-submission for MT-RNR1 filed to FDA

(Alliance News) - Genedrive PLC on Wednesday said it has started engagement with the US Food & Drug Administration to progress the approval of its MT-RNR1 product range into the US.

Read more
5 Oct 2022 11:03

Genedrive engages with US FDA over infant test

(Sharecast News) - Near-patient molecular diagnostics company Genedrive has started engaging with the US Food and Drug Administration (FDA), it announced on Wednesday, to progress the regulatory approval of its 'MT-RNR1 ID Kit' into the United States.

Read more
26 Sep 2022 14:24

Genedrive says its "world first" test has been accelerated by NICE

(Alliance News) - Genedrive PLC on Monday said that its Genedrive MT-RNR1 test has been accelerated by the UK's National Institute for Health & Clinical Excellence.

Read more
26 Sep 2022 14:10

Genedrive test to go through new, faster NICE process

(Sharecast News) - Molecular diagnostics technology company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has transferred the evaluation of its 'MT-RNR1' test to a new 'early value assessment programme'.

Read more
22 Aug 2022 11:48

Genedrive's CYP2C19 ID Kit included in UK's NICE assessment

(Alliance News) - Genedrive PLC on Monday said the UK's National Institute for Health & Clinical Excellence has begun an evaluation of CYP2C19 genotype testing for Clopidogrel treatment.

Read more
22 Aug 2022 10:39

Another Genedrive test to be assessed by NICE

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has started an evaluation of CYP2C19 genotype testing for clopidogrel treatment, via a new NICE diagnostics assessment programme (DAP).

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.